Zolbetuximab: research progress and prospects in the treatment of gastric and gastroesophageal junction cancer targeting claudin 18.2
Attendere...
Maggio 2026, Vol. 117, N. 5
Recenti Prog Med 2026;117(5):223-229
doi 10.1701/4698.47106